A Follow-up Study for Chinese Chronic Hepatitis C Patients Treated with the Combination of PEG-IFNα-2a (PEGASYS) and Ribavirin

A Follow-up Study for Chinese Chronic Hepatitis C Patients Treated with the Combination of PEG-IFNα-2a (PEGASYS) and Ribavirin

Objective To compare the efficacy of peginterferon alfa-2a (PEGASYS) plus ribavirin (RBV) with interferon alfa-2a plus RBV, and evaluate the safety.

Bibliographic Details
Main Authors: Chen Zhu, Zeng Yi-lan, Wang Li, Hu Rong, Wang Yan, Tang Yu-zhen, Zhu Li, Wu Bei
Format: Article
Language:English
Published: Sciendo 2014-09-01
Series:Infection International
Subjects:
Chronic hepatitis C
Interferon alpha
Ribavirin
Treatment outcome
Online Access:http://www.degruyter.com/view/j/ii.2014.3.issue-3/ii-2017-0083/ii-2017-0083.xml?format=INT

Internet

http://www.degruyter.com/view/j/ii.2014.3.issue-3/ii-2017-0083/ii-2017-0083.xml?format=INT

Similar Items